NexGen Data Systems is an emerging, technologies-focused company providing expert data systems engineering, operations, and management solutions to commercial and government customers. NexGen Data Systems promotes a culture of knowledge and career advancement through continued learning, keeping our team members current on the latest advances in information technologies, and enabling our team to provide the best available solutions to our customers.
Optimum Data Inc. is an industry leading provider of new and refurbished networking equipment, optics, servers, and IT hardware repair. As one of the few companies that have been in business for 30+ years we have the knowledge and expertise to fit any size of customer and industry.
As an independent solutions company we are able to provide the best pricing and options for a range of demands. When it comes to your specific needs you should not be pushed onto the industry’s agenda and products. With our global reach in equipment and service we can support and provide equipment from any generation and from all brands including Cisco, Dell, HP/Aruba, Arista and more.
Take a step to explore cost-saving and time-saving options for your company, become the force that strives for change in the industry. With the current times it is more important than ever to find solutions geared towards your size of company and your budget.
ALTEN (www.alten.com) acquires the European Contract Research Organization Advanced Drug & Device Services (ADDS) and regroups its Life Sciences solutions in a new structure, APROVA, headquartered in Brussels.
With annual revenues of 1 198 M€ in 2012 and 15 950 co-workers worldwide (among them 88% of high-level engineers and scientists working for large companies), ALTEN is the European leader in Engineering and Consulting.
APROVA is an international Contract Research Organization (CRO) and Contract Safety Organization (CSO) with offices in Belgium, France, the Czech Republic and Israel and with a capacity to manage trials all over Europe (including Ukraine and Russia). It provides global services to its clients in the pharmaceutical, medical devices, biotechnology, nutritional and cosmetics industries.
Aprova collaborates closely with its clients to ensure that services are provided in the manner that fits most appropriately with their strategic and operational requirements. Its services include end-to-end clinical trial services, functional services provider (FSP) model (service centers), expert consulting, as well as resourcing.
APROVA also offers Educational programs in clinical research and in pharmaco and materiovigilance.
Presently, ADDS is managing Phase II and Phase III studies in more than 18 European countries
Please contact for any further information:
Patrice Le Guen (Business Development Manager): +33 (0)6 71 44 01 90 (pleguen@aprova-cro.com)